Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2011
09/29/2011US20110236927 Genetically stabilized tandem gene duplication
09/29/2011US20110236926 Host Cells and Methods Of Producing Disulfide Bond Containing Proteins
09/29/2011US20110236925 Method of Obtaining a Purified, Biologically Active Heterologous Protein
09/29/2011US20110236900 Novel muts protein and method for determing mutation using the same
09/29/2011US20110236554 Hydrolysed protein-polysaccharide complexes
09/29/2011US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
09/29/2011US20110236420 Bluetongue virus recombinant vaccines and uses thereof
09/29/2011US20110236416 Foot and mouth disease virus recombinant vaccines and uses thereof
09/29/2011US20110236408 Respiratory synctial virus (rsv) sequences for protein expression and vaccines
09/29/2011US20110236404 Methods for Protein Expression in Mammalian Cells in Serum-Free Medium
09/29/2011US20110236393 Monoclonal antibody production in b cells and uses therof
09/29/2011US20110236388 Bispecific, bivalent anti-vegf/anti-ang-2 antibodies
09/29/2011US20110236380 Ligands that bind il-13
09/29/2011US20110236375 Antibody variants with enhanced complement activity
09/29/2011US20110236372 Display Library for Antibody Selection
09/29/2011DE19641876B4 Streptavidinmuteine Streptavidin muteins
09/29/2011CA2794167A1 Bmp-7 peptides & methods of use
09/29/2011CA2794165A1 Bmp-4 peptides & methods of use
09/28/2011EP2369005A1 Biological active proteins having increased in vivo and/or in vitro stability
09/28/2011EP2368986A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof
09/28/2011EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
09/28/2011EP2368907A2 Anti-Abeta antibodies and their use
09/28/2011EP2368904A1 Regulatable growth of filamentous fungi
09/28/2011EP2368579A1 Transglutaminase mediated conjugation of peptides
09/28/2011EP2367935A1 Acidothermus celluloyticus xylanase
09/28/2011EP1937827B1 Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with sod1 abnormalities
09/28/2011EP1649041B1 Multimeric oxidoreductases
09/28/2011EP1633865B1 New biological entities and the use thereof
09/28/2011EP1605890B1 Kit for pharmaceutical use
09/28/2011EP1523498B1 Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives
09/28/2011EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO
09/28/2011EP1144613B1 Methods for making proteins containing free cysteine residues
09/28/2011CN1905899B EphA2 agonistic monoclonal antibodies and methods of use thereof
09/28/2011CN1732259B Method of degrading hardly degradable protein
09/28/2011CN102203286A Determination of immunoglobulin encoding nucleid acid
09/28/2011CN102203123A Novel tools for the production of glycosylated proteins in host cells
09/28/2011CN102203113A Clarification process
09/28/2011CN102199650A Instant sericin powder and preparation method thereof
09/28/2011CN102199649A Method for classifying molecular weights of fish collagen peptides
09/28/2011CN102199648A Method for acquiring bioactive peptide by sequentially hydrolyzing deer haemproteins with two enzymes
09/28/2011CN102199647A Method for separation and extraction of active peptide from domestic fungus by-products
09/28/2011CN102199646A Method for preparing collagen peptide with fish skin
09/28/2011CN102199645A Preparation technology of metallothionein in psychrophilic rhodotorula
09/28/2011CN102199628A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
09/28/2011CN102199623A New application of protein Arginine methyltransferase 5
09/28/2011CN102199600A Gene for adjusting vein color and application thereof
09/28/2011CN102199486A Method for integrated utilizing sunflower seeds
09/28/2011CN102199216A New dendritic cell co-stimulatory molecules
09/28/2011CN102199215A MAPWA fusion antibacterial peptide, preparation method and application thereof
09/28/2011CN101550179B Sesbania peptone and production method thereof
09/28/2011CN101253194B Growth-stimulating polypeptides for use in fish and crustaceans
09/28/2011CN101210043B Rice bran immune peptide and preparing method thereof
09/27/2011US8026354 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
09/27/2011US8026353 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases
09/27/2011US8026351 Monocyte-derived nucleic acids and related compositions and methods
09/27/2011US8026343 Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof
09/27/2011US8026342 Compositions and methods for binding sphingosine-1-phosphate
09/27/2011US8026213 Methods for treating muscle diseases and disorders
09/27/2011US8026109 Hapten-carrier conjugates for treating and preventing nicotine addiction
09/27/2011US8026092 Replication competent hepatitis C virus and methods of use
09/27/2011US8026089 Mutant Δ8 desaturase genes engineered by targeted mutagenesis and their use in making polyunsaturated fatty acids
09/27/2011US8026088 Angiogenic tyrosyl tRNA synthetase compositions and methods
09/27/2011US8026085 Methods and systems for selective fluorination of organic molecules
09/27/2011US8026083 Yarrowia lipolytica and Pichia pastoris HAC1 nucleic acids
09/27/2011US8026082 Synthetic gene control region
09/27/2011US8026072 Method of identifying compounds that bind BAFF-R
09/27/2011US8025886 Modified VEGF-A with improved angiogenic properties
09/27/2011US8025883 Antagonists and methods for inhibiting angiogenesis
09/27/2011US8025877 Methods of using humanized antibodies and compositions for binding sphingosine-1-phosphate
09/27/2011US8025873 Chimeric antigens for eliciting an immune response
09/27/2011CA2608848C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
09/27/2011CA2558805C Anti-myostatin antibodies
09/27/2011CA2377519C Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
09/27/2011CA2369973C Preparation of pancreatic procarboxypeptidase b, isoforms and muteins thereof and their use
09/27/2011CA2336218C Neurotrophic factors
09/27/2011CA2283058C Procedure for simultaneous determination of hiv antigens and hiv antibodies
09/27/2011CA2213331C Chemokine receptors 88-2b [ckr-3] and 88c and their antibodies
09/22/2011WO2011116387A1 Production of aglycosylated monoclonal antibodies in ciliates
09/22/2011WO2011116291A1 Production of human c1 inhibitor in human cells
09/22/2011WO2011115538A1 Production of proteins and polypeptides
09/22/2011WO2011115231A1 Osteopontin specific monoclonal antibody
09/22/2011WO2011073925A9 C. histolyticum recombinant collagenases and method for the manufacture thereof
09/22/2011US20110231944 B cell-derived ips cells and application thereof
09/22/2011US20110230646 Hybrid antibodies
09/22/2011US20110230642 Method for increasing recloning efficiency
09/22/2011US20110230637 Modified human thymic stromal lymphopoietin
09/22/2011US20110230421 Fusion proteins of apoptin-protein transduction domain of carboxyl-terminus of ec-sod
09/22/2011US20110230416 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates
09/22/2011US20110230405 Peptides and Supported Peptides for Treating Skin Diseases
09/22/2011US20110230404 Glycoproteins Produced in Plants and Methods of Their Use
09/22/2011US20110230392 Novel narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, and narc 25 molecules and uses therefor
09/22/2011US20110230374 High affinity recombinant sea lamprey antibodies selected by a yeast surface display platform
09/22/2011US20110229964 Fusion Protein Delivery System and Uses Thereof
09/22/2011US20110229935 Process for the production of the actinobacillus pleuropneumoniae toxin apxi employing a culture medium comprising calcium-borogluconate complex
09/22/2011US20110229934 Process for the production of the actinobacillus pleuropneumoniae toxins apxi or apciii in a liquid culture medium under supply of air enriched in carbon dioxide
09/22/2011US20110229933 High titer antibody production
09/22/2011US20110229932 Artificial chromosome vector
09/22/2011US20110229931 Engineering intracellular sialylation pathways
09/22/2011US20110229903 Determination of immunoglobulin encoding nucleic acid
09/22/2011US20110229873 Fermentation process using specific oxygen uptake rates as a process control